Table III.
VACV-derived immunoprevalent Ags
Ag Name | VACV-WR Name | Peptide Sequence | Restriction | Ref. |
---|---|---|---|---|
— | 148 | NLWNGIVPT | HLA-A*0201 | Snyder et al. (11) |
— | 148 | YLYTEYFLFL | HLA-A*0201 | Oseroff et al. (2) |
— | 148 | SIYQYVRL | H-2Kb | Moutaftsi et al. (1) |
— | 148 | KYQQDRDTL | H-2Kd | |
— | 148 | IPAALIILL | H-2Ld | |
A3L | 122 | DEVASTHDW | HLA-B*4403 | Jing et al. (6) |
A3L | 122 | YEFRKVKSY | HLA-B*4403 | Jing et al. (6) |
A3L | 122 | KSYNYMLL | H-2Kb | Moutaftsi et al. (1) |
A3L | 122 | YSPSNHHIL | H-2Db | Moutaftsi et al. (1) |
A3L | 122 | IYSPSNHHI | H-2Kd | |
A47L | 173 | AFEFINSLLK | HLA-A*1101; H-2b | Pasquetto et al. (3) |
A47L | 173 | LLYAHINAL | HLA-A*0201 | Terajima et al. (9) |
A47L | 173 | AAFEFINSL | H-2Kb | Tscharke et al. (14); Moutaftsi et al. (1) |
A47L | 173 | TMMINPFMI | H-2Db | Moutaftsi et al. (1) |
A47L | 173 | AHINALEY | H-2Db | Mathew et al. (30) |
A47L | 173 | KIIQKSSSI | H-2Kd | |
B8R | 190 | DMCDIYLLY | HLA-A*0101; -A*2601; -A*2902 | Oseroff et al. (2) |
B8R | 190 | FGDSKEPVPY | HLA-A*0101; -*2601; -A*2902 | Oseroff et al. (2) |
B8R | 190 | FLSMLNLYKY | HLA-A*0101; -A*2902 | Oseroff et al. (2) |
B8R | 190 | TEYDDHINL | HLA-B*4001 | Oseroff et al. (2) |
B8R | 190 | TSYKFESV | H-2Kb | Tscharke et al. (15); Moutaftsi et al. (1) |
D1R | 106 | FTIDFKLKY | HLA-A*2601; -A*2902 | Oseroff et al. (2) |
D1R | 106 | KTKNFTIDFK | HLA-A*0301 | Oseroff et al. (2) |
D1R | 106 | HPRHYATVM | HLA-B*0702 | Oseroff et al. (2) |
D1R | 106 | RPSTRNFFEL | HLA-B*0702 | Pasquetto et al. (3, 30) |
D1R | 106 | EERHIFLDY | HLA-B*4403 | Jing et al. (6) |
D1R | 106 | LGYIIRYPV | H-2Kb | Moutaftsi et al. (1) |
D1R | 106 | SMYCSKTFL | H-2Db | Moutaftsi et al. (1) |
D1R | 106 | KYEGPFTTT | H-2Kd | |
D1R | 106 | KYFYGEIAL | H-2 Kd | |
D1R | 106 | KFINGASTM | H-2Kd | |
D5R | 110 | EEIPDFAFY | HLA-B*4403 | Jing et al. (6) |
D5R | 110 | LENGAIRIY | HLA-B*4403 | Jing et al. (6) |
D5R | 110 | RYRFAFLYLL | HLA-A*2402 | Oseroff et al. (2) |
D5R | 110 | VWINNSWKF | HLA-A*2402; - A*2301 | Oseroff et al. (2) |
D5R | 110 | YLLVKWYRK | HLA-A*3303 | Oseroff et al. (2) |
D5R | 110 | SKIFINSII | H-2Kd | |
D5R | 110 | TYTTMDTLI | H-2Kd | |
D5R | 110 | YYFSLQQRL | H-2Kd | |
E9L | 65 | FLNISWFYI | HLA-A*0201 | Oseroff et al. (2) |
E9L | 65 | RMNSNQVCI | H-2Db | Moutaftsi et al. (1) |
E9L | 65 | NPLSNPFYM | H-2Ld | |
J6R | 98 | NQVKFYFNK | HLA-A*0301 | Oseroff et al. (2) |
J6R | 98 | MPAYIRNTL | HLA-B*0702 | Oseroff et al. (2) |
J6R | 98 | INFEFVCL | H-2Kb | Moutaftsi et al. (1) |
J6R | 98 | KYAANYTKI | H-2Kd | |
J6R | 98 | KYFFTVSNI | H-2Kd | |
J6R | 98 | RYNVIASSI | H-2Kd | |
M1L | 30 | IIIPFIAYFV | HLA-A*0201 | Pasquetto et al. (3) |
M1L | 30 | TSNVITDQTV | H-2Db | Moutaftsi et al. (1) |